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The nature and functions of cells creating hematopoietic niches during inflammation remain incompletely
understood. In this issue of Immunity, Kwak et al. (2015) reveal that myeloid cell-produced reactive oxygen
species stimulate proliferation of myeloid progenitors establishing an additional mechanism to regulate
hematopoiesis.Most blood cells, including immune cells,
are generated from hematopoietic stem
cells (HSCs) in the bone marrow. The
proliferation and differentiation of HSCs
and their progeny, including various pop-
ulations of hematopoietic progenitor cells,
are regulated by special microenviron-
ments known as niches to provide appro-
priate numbers of mature blood cells
during homeostasis and in response to
bone-marrow stressors, including inflam-
mation. The identity of the niche has been
a subject of longstanding debate. Efforts
over the past decade have focused
on non-hematopoietic cells and many
studies have identified diverse candidate
cells, which create a niche for HSCs in
the marrow, including osteoblasts lining
the bone surface, endothelial cells and
mesenchymal cells such as CXC chemo-
kine ligand (CXCL)12-abundant reticular
(CAR) cells, stem cell factor (SCF)-ex-
pressing cells, nestin-GFP+NG2+ cells
and platelet-derived growth factor recep-
tor a (PDGFRa)+Sca-1+CD45Ter119
(PaS) cells, as well as GFAP-expressing
nonmyelinating Schwann cells (Kunisaki
et al., 2013; Morrison and Scadden,
2014; Omatsu et al., 2014; Sugiyama
et al., 2006). Of note, recent studies
have demonstrated that CAR cells with
potential to differentiate into adipocytes
and osteoblasts, which are largely equiva-
lent to SCF-expressing cells and do not
express nestin or Sca-1, specifically ex-
press leptin receptor (Lepr) and the critical
transcription factor Foxc1 (Morrison and
Scadden, 2014; Omatsu et al., 2014; Su-
giyama et al., 2006). Furthermore, of the
candidate niches, endothelial cells and
CAR cells have been shown to play
an essential role in the maintenance ofhematopoietic stem and progenitor cells
(HSPCs) in vivo, meeting the criteria for
HSPC niches (Morrison and Scadden,
2014; Omatsu et al., 2014). However, the
function of nestin-GFP+NG2+ cells in he-
matopoiesis has proven difficult to study
because nestin and NG2 are also ex-
pressed in endothelial cells, osteoblasts,
and Schwann cells (Kunisaki et al., 2013;
Zhou et al., 2014).
In contrast to niches for HSPC mainte-
nance during homeostasis, the nature
and functions of cells creating HSPC
niches in response to inflammation
remain incompletely understood. During
infection, steady-state hematopoiesis is
changed to massively enhanced myeloid
cell production, termed ‘‘emergencymye-
lopoiesis.’’ In these processes, HSPCs
are thought to respond directly to infec-
tious stimuli and proliferate to replenish
immune cells (Baldridge et al., 2011). In
addition to HSPC responses, emigration
of inflammatory monocytes and neutro-
phils from bone marrow to bloodstream
is critical for innate immune defense
against microbial pathogens. It has been
shown previously that expression of the
CC chemokine ligand (CCL)2, also known
as monocyte chemoattractant protein-1
(MCP1), significantly increased in CAR
cells and endothelial cells at 4 hr after
administration of low concentrations of
the Toll-like receptor (TLR) ligands LPS
and that upregulation of CCL2 in endo-
thelial cells and CAR cells is required for
emigration of inflammatory monocyte
from the bone marrow into the circulation
in response to bacterial infection (Shi
et al., 2011).
On the other hand, a recent study
has shown that endothelial cell-intrinsicImmunity 4myeloid differentiation primary response
gene 88 (Myd88) is required for granulo-
cyte colony-stimulating factor (G-CSF)
production by endothelial cells and accel-
erated neutrophil generation in bone
marrow after administration of high con-
centrations of LPS or bacterial infection
with Escherichia coli (E. coli) (Boettcher
et al., 2014). Because TLRs recognize
conserved molecular patterns found on
pathogens and signal via the adaptor pro-
tein,Myd88, this indicates that endothelial
cells expressing TLR4 and Myd88 are the
prime sources of G-CSF, which catalyze
the detection of infection into emergency
myelopoiesis.
In this issue of Immunity, Kwak et al.
have shown that inflammation-induced
reactive oxygen species (ROS) production
in mature myeloid cells played a critical
role in proliferation of adjacent myeloid
progenitors, resulting in emergency mye-
lopoiesis. They have revealed that the
gp91 subunit of NADPH oxidase holoen-
zyme NOX2, which produces ROS, is
specifically expressed in mature myeloid
cells in bone marrow and that the
concentration of ROS in themarrow extra-
cellular space increased gradually, reach-
ing a peak by 48 hr after injection of heat-
inactivated E. coli, which induces acute
peritoneal inflammation, accompanied
by the expansion of granulocyte/macro-
phage progenitors (GMPs) 36 hr after the
E. coli injection (Kwak et al., 2015). To
examine the role of myeloid cells or non-
hematopoietic niche cells on E. coli-
induced GMP expansion, Kwak et al.
injected primitive hematopoietic cells,
includingHSCs, into irradiatedor non-irra-
diated CGD mice, in which the gp91 sub-
unit of NOX2 was deleted, to generate2, January 20, 2015 ª2015 Elsevier Inc. 13
Figure 1. Schematic View of Interactions between Myeloid Cells, Myeloid Progenitors, and
Non-hematopoietic Cells of HSPC Niches during Infection
In bone marrow, proliferation of myeloid progenitor (GMP) is enhanced by ROS in the extracellular space
produced by their myeloid lineage progeny in response to infectious stimuli. Endothelial cells (ECs) are the
prime sources of G-CSF, which is dispensable for ROS production by myeloid cells, and play a critical role
in enhanced myelopoiesis, and CCL2 upregulated in ECs and CAR cells is required for monocyte emigra-
tion from the bone marrow into the circulation in response to bacterial infection.
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Previewsmixed chimeric mice. Primitive hemato-
poietic cells engrafted irradiated and
non-irradiatedmicewith stable chimerism
of around 100% and 0.4%, respectively,
over 6 weeks. Kwak et al. revealed that
E. coli-induced expansion of donor-
derived GMPs was observed in irradiated
CGD mice reconstituted with wild-type
hematopoietic cells but was abolished in
non-irradiated CGD mice containing only
a small numbers of wild-type hematopoi-
etic cells, suggesting that hematopoietic
cell-intrinsic gp90 is essential for E. coli-
induced GMP expansion.
In addition, Kwak et al. revealed that
heat-inactivated E. coli injection induced
phosphatase and tensin homolog (PTEN)
oxidation, which inhibited the lipid phos-
phatase activity of PTEN, and Akt phos-
phorylation were abolished in LinSca-
1c-kit+ (LK) hematopoietic progenitors,
including GMPs, from CGD mice and14 Immunity 42, January 20, 2015 ª2015 Elsthat a specific PI3Kdelta inhibitor sup-
pressed E. coli-induced expansion of
GMPs, suggesting that emergency GMP
expansion was mediated by ROS-elicited
PTEN oxidation and deactivation, result-
ing in PI3K (delta) activation and Akt phos-
phorylation in GMPs. Together with the
histological data that all c-kit+ progeni-
tors, including GMPs, were adjacent to
Gr-1+ myeloid cells in the marrow, Kwak
et al. conclude that myeloid-cell-pro-
duced ROS stimulated proliferation of
myeloid progenitors via a paracrine
mechanism in bone marrow during acute
infection.
The finding by Kwak et al. that prolifer-
ation of hematopoietic progenitor cells is
enhanced by ROS in the marrow extracel-
lular space produced by their progeny
establishes an additional mechanism to
regulate hematopoiesis in times of stress,
parallel to the signals produced by theevier Inc.non-hematopoietic cells of the HSPC
niche (Figure 1). Similar mechanisms
have been shown to be utilized in the
Drosophila hematopoietic organ, in
which an enzyme adenosine deaminase
secreted from differentiatingmyeloid cells
maintain quiescence and numbers of their
progenitors during homeostasis (Mondal
et al., 2011). Considering that many
HSPCs are in contact with endothelial
cells and/or the processes of CAR cells
in the marrow (Morrison and Scadden,
2014; Sugiyama et al., 2006), non-
hematopoietic cells of the HSPC niche
might be involved in productive interac-
tion between myeloid cells and their
progenitors during infection. It will be
important and interesting to determine
whether similar mechanisms apply to
other processes whereby bone marrow
microenvironments provide appropriate
numbers of hematopoietic cells during
homeostasis and in response to a diverse
variety of infectious stimuli.
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